Tapering Considerations: Gradually reduce GLP-1 dosing while increasing fiber and protein intake Begin nutraceutical support (e.g., berberine, chromium) 24 weeks prior to taper Monitor lean mass and glycemic variability Support appetite signaling with mindful eating and circadian regulation Address gut motility and emotional eating patterns with botanical support Clinical Example: A Case in Practice A 52-year-old female on semaglutide for 6 months presented with nausea, fatigue, and concern about lean mass loss
Tirzepatide may offer stronger weight and insulin-sensitivity effects than semaglutide in broader studies, but PCOS-specific head-to-head data remain limited
Evening GLP-1 Dosing: When It Works Better for You Evening or bedtime dosing positions medication peaks during sleep and early morning hours, minimizing the chance nausea interferes with work, social meals, or exercise
Many patients can successfully manage hair loss while continuing their medication by optimizing nutrition, slowing the rate of weight loss through dose adjustment, and adding hair-supportive treatments
Semaglutide used alongside insulin or insulin-stimulating medications may increase the risk of hypoglycemia
